Showing 10,621 - 10,640 results of 28,667 for search '(( 5 ((ng decrease) OR (nn decrease)) ) OR ( 50 ((we decrease) OR (a decrease)) ))', query time: 0.58s Refine Results
  1. 10621

    Biosynthesis, characterisation and biocompatibility of a unique and elastomeric medium chain-length polyhydroxyalkanoates for kidney glomerular tissue engineering by Syed Mohammad Daniel Syed Mohamed (19836277)

    Published 2025
    “…These polymers are not only highly biocompatible in nature but also sustainable, produced using renewable substrates, and hence considered future biomaterials. This study explores a medium chain-length PHA (mcl-PHA) produced by <em>Pseudomonas mendocina </em>CH50 by batch fermentation, fed with glucose as the sole carbon source. …”
  2. 10622

    Table_1_Association between dietary habits and incident thyroid cancer: A prospective cohort study.DOCX by Linh Thi Dieu Nguyen (14619104)

    Published 2023
    “…However, this association was limited to individuals aged ≥ 50 years (aHR, 0.49; 95% CI, 0.31–0.79), women (aHR, 0.61; 95% CI, 0.41–0.90), and non-smokers (aHR, 0.62; 95% CI, 0.41–0.92).…”
  3. 10623

    Image_1_Triglyceride–glucose index change and chronic kidney disease progression in a Chinese hypertensive population.pdf by Chao Yu (562804)

    Published 2024
    “…The study’s outcome variable was the progression of CKD, defined as follows: for subjects with an estimated glomerular filtration rate (eGFR) ≥60 mL/min, a ≥30% decrease in eGFR with a final follow-up value <60 mL/min; for those with an eGFR <60 mL/min, a50% decrease in eGFR; or terminal renal failure requiring dialysis.…”
  4. 10624
  5. 10625
  6. 10626
  7. 10627
  8. 10628
  9. 10629
  10. 10630
  11. 10631
  12. 10632
  13. 10633
  14. 10634
  15. 10635

    Data_Sheet_1_Nanoformulation of Talazoparib Delays Tumor Progression and Ascites Formation in a Late Stage Cancer Model.pdf by Paige Baldwin (6688517)

    Published 2019
    “…However, its potency lends itself to side effects associated more closely with traditional chemotherapeutics than other clinically approved PARP inhbitors. We sought to formulate Talazoparib in a nanoparticle delivery system, which allows the drug to be administered intraperitoneally. …”
  16. 10636

    DataSheet_1_Molecular mechanisms regulating natural menopause in the female ovary: a study based on transcriptomic data.xlsx by Quan Liu (486219)

    Published 2023
    “…Increased contents of terminally differentiated HMGB1+ Granulosa and GSTA1+ Granulosa were observed in the ovaries of individuals aged 50-69. Signaling pathway activity analysis indicated a gradual decrease in TGFb and MAPK pathway activity with menopause progression, while p53 pathway activity increased. …”
  17. 10637
  18. 10638
  19. 10639
  20. 10640